| Primary |
| Diabetes Mellitus |
42.9% |
| Type 2 Diabetes Mellitus |
42.9% |
| Hypertension |
3.6% |
| Diabetes Mellitus Management |
2.4% |
| Back Pain |
1.2% |
| Blood Glucose Abnormal |
1.2% |
| Constipation |
1.2% |
| Diabetic Neuropathy |
1.2% |
| Dyslipidaemia |
1.2% |
| Hyperglycaemia |
1.2% |
| Product Used For Unknown Indication |
1.2% |
|
| Pancreatitis Acute |
22.9% |
| Pancreatitis |
10.4% |
| Stevens-johnson Syndrome |
8.3% |
| Death |
6.3% |
| Hypoglycaemic Coma |
6.3% |
| Sudden Death |
6.3% |
| Ileus |
4.2% |
| Platelet Count Decreased |
4.2% |
| Renal Cyst |
4.2% |
| Renal Failure Acute |
4.2% |
| Vomiting |
4.2% |
| Altered State Of Consciousness |
2.1% |
| Angioedema |
2.1% |
| Aplasia Pure Red Cell |
2.1% |
| Cardiac Failure |
2.1% |
| Diabetic Neuropathy |
2.1% |
| Gastroenteritis Viral |
2.1% |
| Haematuria |
2.1% |
| Hemiparesis |
2.1% |
| Herpes Zoster |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
28.7% |
| Diabetes Mellitus |
17.4% |
| Type 2 Diabetes Mellitus |
14.8% |
| Hypertension |
6.1% |
| Chronic Hepatitis C |
5.2% |
| Hypercholesterolaemia |
4.3% |
| Dyslipidaemia |
3.5% |
| Constipation |
2.6% |
| Diuretic Therapy |
2.6% |
| Osteoporosis |
2.6% |
| Acute Myocardial Infarction |
1.7% |
| Atrial Fibrillation |
1.7% |
| Cancer Pain |
1.7% |
| Onychomycosis |
1.7% |
| Chronic Kidney Disease |
0.9% |
| Concomitant Disease Progression |
0.9% |
| Depressive Symptom |
0.9% |
| Diabetic Peripheral Neuropathy |
0.9% |
| Gastric Ulcer |
0.9% |
| Gastritis |
0.9% |
|
| Interstitial Lung Disease |
12.5% |
| Drug Eruption |
9.4% |
| Tremor |
9.4% |
| Dizziness |
6.3% |
| Glossitis |
6.3% |
| Nausea |
6.3% |
| Platelet Count Decreased |
6.3% |
| Pneumatosis Intestinalis |
6.3% |
| Blood Alkaline Phosphatase Increased |
3.1% |
| Blood Creatine Phosphokinase Increased |
3.1% |
| Blood Creatinine Increased |
3.1% |
| Death |
3.1% |
| Eosinophilia |
3.1% |
| Erythema Multiforme |
3.1% |
| Gamma-glutamyltransferase Increased |
3.1% |
| Generalised Erythema |
3.1% |
| Generalised Oedema |
3.1% |
| Haemoptysis |
3.1% |
| Hepatotoxicity |
3.1% |
| Osmotic Demyelination Syndrome |
3.1% |
|
| Concomitant |
| Diabetes Mellitus |
16.4% |
| Hepatitis C |
11.4% |
| Hypertension |
10.4% |
| Product Used For Unknown Indication |
10.1% |
| Prophylaxis |
8.1% |
| Chronic Hepatitis C |
7.3% |
| Type 2 Diabetes Mellitus |
5.7% |
| Insomnia |
3.8% |
| Multiple Myeloma |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Idiopathic Thrombocytopenic Purpura |
2.7% |
| Neuropathy Peripheral |
2.6% |
| Cardiac Failure |
2.4% |
| Hyperlipidaemia |
2.3% |
| Constipation |
2.2% |
| Cardiac Failure Chronic |
1.8% |
| Atrial Fibrillation |
1.7% |
| Hypercholesterolaemia |
1.5% |
| Cerebral Infarction |
1.3% |
| Depression |
1.3% |
|
| Renal Failure Acute |
17.3% |
| White Blood Cell Count Decreased |
12.5% |
| Vomiting |
7.7% |
| Dizziness |
5.8% |
| Malaise |
5.8% |
| Neutrophil Count Decreased |
5.8% |
| Drug Eruption |
3.8% |
| Gastrointestinal Haemorrhage |
3.8% |
| Medication Residue |
3.8% |
| Platelet Count Decreased |
3.8% |
| Renal Impairment |
3.8% |
| Blood Bicarbonate Increased |
2.9% |
| Blood Creatine Phosphokinase Increased |
2.9% |
| Cerebral Infarction |
2.9% |
| Hyperkalaemia |
2.9% |
| Leukaemia |
2.9% |
| Nausea |
2.9% |
| Pneumonia |
2.9% |
| Pyrexia |
2.9% |
| Retinopathy |
2.9% |
|
